Coexistent cardiovascular disease is common in patients presenting for repair of aortic aneurysms. However, preoperative cardiac evaluation prior to abdominal aortic aneurysm (AAA) surgery remains contentious with significant variations in practice between countries, institutions and individual anesthetists. The following case report raises some everyday issues confronting clinical anesthetists.
aneurysm (AAA)b. He had originally presented to his family physician complaining of low back pain of several months duration. He had been treated for hypertension for 10 years and had sustained a myocardial infarction (MI) five years previously. He had no history of angina pectoris and had good exercise tolerance, becoming breathless only on walking uphill briskly. He had no known allergies and was an ex-smoker for 20 years (35-pack/year history). The patient's only previous anesthetic was uneventful. Preoperatively he was taking atenolol 100 mg, bendrofluazide 5 mg daily, nifedipine 20 mg daily and captopril 25 mg BD. The patient's blood pressure was 140/80, and his pulse rate was 56/min. Examination of the airway, cardiovascular and respiratory systems was unremarkable.
An ECG showed sinus bradycardia of 56/min, left-axis deviation and left bundle branch block. The chest X-ray was normal. An echocardiogram showed an ejection fraction of 58 percent with regional wall dyskinesia in the left ventricle. Of note in the blood biochemistry was a low potassium of 2.9 mmol/l and a slightly elevated urea at 7.2 mmol/l; creatinine was 88 pmol/l.
On the morning of surgery, the patient received his usual medications (atenolol, bendrofluazide, nifedipine and captopril), and he was premedicated with diazepam 10 [2] . A preoperative dipyridamole-thallium scan or dobutamine stress echocardiography was indicated according to these guidelines. In general, a less invasive approach is taken in Ireland and in the United Kingdom to preoperative assessment and treatment of patients with coronary artery disease (CAD) presenting for AAA repair. The rationale for this is that the benefits of an aggressive approach have not been proven to date, even among patients with preoperative mild stable angina [3] [4] [5] . Nevertheless, there are reports showing that prior MI is associated with adverse outcomes (death or MI) following AAA repair [6, 7] . Furthermore, among patients with left bundle branch block, those with left-axis deviation have a greater incidence of myocardial dysfunction, more advanced conduction disease and greater cardiovascular mortality than those with a normal axis [8] . Hence The bradycardia shown on the ECG was thought to be the result of beta-blockade. An overview of studies examining the perioperative risks in patients with preoperative conduction disturbance concluded that fewer than two percent of patients with chronic bifascicular block (either left bundle branch block or right bundle branch block combined with left anterior or posterior hemiblock) progressed to complete heart block during surgery [9] . The presence also of a prolonged P-R interval may be suggestive of increased risk of complete heart block, but this is controversial and, in any event, was not relevant to our patient. A significant incidence of perioperative bradyarrthymias in patients with left bundle branch block has recently been reported [10] . The bradyarrthymias in this study responded to pharmacotherapy, and the authors did not recommend prophylactic insertion of a temporary pacemaker.
There is no good evidence that our patient warranted prophylactic pacing. Nevertheless, placement of a central line before induction of anesthesia would have been appropriate, to aid the insertion of a temporary pacing wire if needed. A transcutaneous pacemaker was available for use in the operating theatre had our patient not responded to atropine. The patient was anesthetized and so would have been a good candidate for transcutaneous pacing until transvenous pacing was established. Should one anesthetize a patient for AAA repair with a serum potassium of 2.9 mmolll?
There is little clear evidence one way or the other. This patient's records indicated that the hypokalemia was chronic. Treatment with a thiazide diuretic was the most likely cause for this finding. It should be noted that the dose of bendrofluazide was 5 mg daily rather than the more usual 2.5 mg daily. There is no evidence of increased efficacy but good evidence for increased metabolic disturbance at higher doses of thiazide diuretics. The clinical significance of hypokalemia in thiazide-treated patients is disputed [11] . Indeed, there is even controversy as to whether diuretics really cause significant depletion of total body potassium [12, 13] .
It is not surprising that anesthetists also vary in their responses to hypokalemia. Some would accept this low potassium level arguing that the chronic nature of the hypokalemia would allow restoration of equilibrium at cellular level and maintenance of transmembrane potential. A prospective study of outcome in patients who were chronically hypokalaemic prior to surgery did not show an increase in dysrhythmias intraoperatively [14] . Others argue for respecting a cut-off point for potassium of 3.0 mmol/L-the point below which U waves occur with increasing frequency. Several large studies have shown a correlation between diuretic induced hypokalemia and ventricular ectopic activity [15] [16] [17] . Use of thiazide diuretics is also associated with hypomagnesemia, which may contribute to arrhythmogenesis [18] . Inotropes, such as adrenaline, and bronchodilators, such as salbutamol, have been shown to lower serum potassium [19, 20] . AAA repair is a major procedure expected to take many hours and requiring infusion of large volumes of crystalloid, colloid and blood. Inotropes may be required in the course of surgery or afterwards in the intensive care unit. For these reasons, it is preferable to have normal electrolyte levels preoperatively. There is consensus that rapid correction of chronic hypokalemia by intravenous infusion is undesirable and is associated with significant morbidity [11] . Potassium should ideally be replaced orally over three to four days. Should this patient have received his antihypertensive medications preoperatively?
It is common practice to continue beta-blockers preoperatively on the basis of their cardioprotective effects [21] [22] [23] and to prevent beta-blocker withdrawal syndrome [24] . Calcium channel blockers are also usually continued preoperatively, although the resultant myocardial depression, systemic vasodilation and slowing of atrioventricular conduction may be potentiated by inhalational agents [25] . There has been more concern about whether or not to continue angiotensin converting enzyme (ACE) inhibitors perioperatively [26] . Colson et al. documented significant blood pressure decreases at induction in patients treated with ACE inhibitors [27] . Hemodynamic results indicated that hypotension in this group of patients was due to the inability of the heart to maintain cardiac output during acute changes in ventricular volume. They suggested that crystalloids as well as inotropes were required to control blood pressure in such patients. However, a subsequent study by Sear et al. showed no difference between hemodynamic responses at induction between patients treated with different antihypertensive agents including ACE inhibitors [28] . There is still a lack of documentation in the literature of the effects of multiple antihypertensive therapy on patients at induction.
Was appropriate monitoring in place prior to induction?
The intention had been to insert a central venous line after induction; this did happen but under more stressful conditions than had been envisaged! As previously stated, in view of the ECG findings, it would have been advisable to have had central vein access prior to induction. The benefits of inserting a pulmonary artery flow directed catheter for monitoring during AAA surgery are uncertain [29] and may even be detrimental in critical care patients [30] .
Were suitable induction agents used in this patient?
Fentanyl in low to moderate doses can be associated with a mild bradycardia, which is probably central in origin as it does not occur after vagotomy [31] . Vecuronium is usually stable as regards cardiovascular effects, but bradycardias and some dysrhythmias have been reported. Because vecuronium lacks vagolytic effects, any opioid-induced bradycardia is unopposed when fentanyl and vecuronium are used in combination. Similarly, bradycardia and asystole have been reported following the administration of sufentanil with vecuronium, interestingly in patients who were receiving both beta-blockers and calcium channel blockers [32] . Etomidate in the dose used in this patient has minimal cardiovascular effects, although there is experimental evidence of an increase in central vagal tone [33] . On 
